HA
HAWPY.US Haw Par Corporation Ltd ADR
- Market cap
- USD 2.96B
- P/E
- 14.6x
- P/B
- 0.88x
- ROE
- 9.2%
- Dividend yield
- 2.33%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is HAWPY.US undervalued?
Graham numberHAWPY.US trades 24.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Haw Par Corporation Ltd ADR fundamental analysis
No fundamental analysis for Haw Par Corporation Ltd ADR yet.
Haw Par Corporation Ltd ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Haw Par Corporation Ltd ADR
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist orie…
Full company profileHaw Par Corporation Ltd ADR financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Haw Par Corporation Ltd ADR annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 202M | 223M | 238M | 244M | 111M | 141M | 182M | 232M | 245M | 226M | 469M |
| Gross Profit | 125M | 140M | 146M | 139M | 48.8M | 73.6M | 98.6M | 135M | 134M | 127M | 261M |
| Operating Income | 72.1M | 74.9M | 82.3M | 79.3M | 13.9M | 24.7M | 43.4M | 64.0M | 63.8M | 66.0M | 134M |
| EBITDA | 78.4M | 80.8M | 88.6M | 85.7M | 20.5M | 31.2M | 49.1M | 70.1M | 254M | 72.3M | 147M |
| Net Income | 125M | 122M | 179M | 182M | 120M | 110M | 148M | 217M | 228M | 261M | 436M |
| EPS | 2.28 | 2.22 | 3.24 | 3.30 | 2.17 | 1.99 | 2.68 | 3.91 | 4.12 | 4.72 | 7.89 |
| Balance Sheet | |||||||||||
| Total Assets | 2.64B | 3.26B | 3.03B | 3.24B | 2.95B | 3.28B | 3.65B | 3.59B | 4.28B | 4.42B | 4.87B |
| Total Liabilities | 161M | 187M | 102M | 84.8M | 64.0M | 72.1M | 101M | 117M | 128M | 127M | 134M |
| Shareholders' Equity | 2.48B | 3.08B | 2.93B | 3.16B | 2.89B | 3.21B | 3.55B | 3.48B | 4.15B | 4.29B | 4.74B |
| Cash & Short-term Investments | 710M | 401M | 520M | 3.09B | 2.81B | 3.12B | 3.18B | 3.21B | 3.93B | 835M | 881M |
| Total Debt | 45.8M | 45.0M | 23.3M | 8.76M | 1.78M | 1.52M | 58.4M | 28.5M | 36.3M | 44.3M | 52.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 91.6M | 107M | 127M | 199M | 25.0M | 18.8M | 40.9M | 62.7M | 53.8M | 267M | 409M |
| Capital Expenditure | 2.80M | 8.03M | 3.36M | 2.97M | 7.54M | 4.38M | 19.7M | 7.77M | 3.46M | 2.08M | 5.01M |
| Free Cash Flow | 88.8M | 98.8M | 123M | 196M | 17.5M | 14.5M | 21.2M | 54.9M | 50.3M | 265M | 404M |
| Ratios | |||||||||||
| ROE | 5.1% | 4.0% | 6.1% | 5.8% | 4.2% | 3.4% | 4.2% | 6.2% | 5.5% | 6.1% | 9.2% |
| ROA | 4.7% | 3.8% | 5.9% | 5.6% | 4.1% | 3.4% | 4.1% | 6.0% | 5.3% | 5.9% | 9.0% |
| Net Profit Margin | 62.0% | 55.0% | 75.3% | 74.7% | 107.9% | 78.0% | 81.5% | 93.3% | 93.2% | 115.4% | 93.0% |
| Debt to Equity | 0.02x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Haw Par Corporation Ltd ADR dividends
- Dividend yield
- 2.33%
- Forward dividend
- 1.25 USD
- Payout ratio
- 116.7%
- Ex-dividend date
- Aug 25, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SGD 305M | 5.51 | 116.7% |
| 2024 | SGD 88.5M | 1.60 | 38.8% |
| 2023 | SGD 77.5M | 1.40 | 35.8% |
| 2022 | SGD 66.4M | 1.20 | 44.8% |
| 2021 | USD 66.4M | 1.20 | 60.3% |
| 2020 | USD 66.4M | 1.20 | 55.4% |
| 2019 | USD 254M | 4.60 | 139.5% |
| 2018 | USD 55.2M | 1.00 | 30.8% |
| 2017 | SGD 44.0M | 0.80 | 35.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Haw Par Corporation Ltd ADR
Ownership data of Haw Par Corporation Ltd ADR is not available yet.
Haw Par Corporation Ltd ADR company profile
- Company name
- Haw Par Corporation Ltd ADR
- Ticker
- HAWPY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- No. 03-03 Haw Par Technocentre, Singapore, Singapore, 149598
- Phone
- 65 6337 9102
- Website
- hawpar.com
About Haw Par Corporation Ltd ADR
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development; and owning and letting properties; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.
Haw Par Corporation Ltd ADR management
7- Mr. Ee Lim WeeCEO, President & Executive Non-Independent Director · born 1961
- Mr. Say Suan Chow C.F.A.Chief Financial Officer
- Ms. Cindy OwDirector of Human Resource
- Mr. Mui Lick KowHead of Quality & Regulatory Affairs
- Ms. Lily SuGroup Internal Audit Manager
- Mr. Kun Long ChiewGroup Finance Manager & Company Secretary
- Mr. Brian LooGroup General Manager